These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 28698014)

  • 21. Evaluation and Comparison of the Potential Immunogenicity of Two Commercial Inactivated Bivalent Newcastle and Avian Influenza Vaccines in SPF Chicken.
    Mehrabanpour M
    Arch Razi Inst; 2019 Sep; 74(3):251-257. PubMed ID: 31592590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus-like particle vaccine confers protection against a lethal newcastle disease virus challenge in chickens and allows a strategy of differentiating infected from vaccinated animals.
    Park JK; Lee DH; Yuk SS; Tseren-Ochir EO; Kwon JH; Noh JY; Kim BY; Choi SW; Kang SM; Lee JB; Park SY; Choi IS; Song CS
    Clin Vaccine Immunol; 2014 Mar; 21(3):360-5. PubMed ID: 24403523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of a novel DNA vaccine candidate targeting F gene of genotype VII Newcastle disease virus and chicken IL-18 delivered by Salmonella.
    Gao X; Xu K; Yang G; Shi C; Huang H; Wang J; Yang W; Liu J; Liu Q; Kang Y; Jiang Y; Wang C
    J Appl Microbiol; 2019 May; 126(5):1362-1372. PubMed ID: 30785663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges.
    Hu Z; Liu X; Jiao X; Liu X
    Vaccine; 2017 Dec; 35(48 Pt B):6585-6590. PubMed ID: 29042201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy enhancement of a Baculovirus-vectored Newcastle Disease Virus F protein vaccine by chicken GM-CSF and IL-2].
    Yu H; Gao D; Shen Y; Liu Y; Ping W; Ge J
    Sheng Wu Gong Cheng Xue Bao; 2018 Sep; 34(9):1442-1452. PubMed ID: 30255678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ascaridia galli infection influences the development of both humoral and cell-mediated immunity after Newcastle Disease vaccination in chickens.
    Pleidrup J; Dalgaard TS; Norup LR; Permin A; Schou TW; Skovgaard K; Vadekær DF; Jungersen G; Sørensen P; Juul-Madsen HR
    Vaccine; 2014 Jan; 32(3):383-92. PubMed ID: 24269617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and biological characterization of the immunological potency of Newcastle disease virus oil emulsion-inactivated vaccines prepared from field isolate obtained from vaccinated chickens outbreak.
    Hassan MI; Abd El-Azeem MW; Selim A; Sultan S
    Braz J Microbiol; 2020 Jun; 51(2):815-826. PubMed ID: 31840214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the Impact of Different Administration Routes on the Efficacy of a Thermoresistant Newcastle Disease Vaccine in Chickens.
    Hassanzadeh M; Abdoshah M; Yousefi AR; Masoudi S
    Viral Immunol; 2020 Jun; 33(5):361-366. PubMed ID: 31976824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective immune responses induced by in ovo immunization with recombinant adenoviruses expressing spike (S1) glycoprotein of infectious bronchitis virus fused/co-administered with granulocyte-macrophage colony stimulating factor.
    Zeshan B; Mushtaq MH; Wang X; Li W; Jiang P
    Vet Microbiol; 2011 Feb; 148(1):8-17. PubMed ID: 20850939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoadjuvant activities of a recombinant chicken IL-12 in chickens vaccinated with Newcastle disease virus recombinant HN protein.
    Su BS; Yin HS; Chiu HH; Hung LH; Huang JP; Shien JH; Lee LH
    Vet Microbiol; 2011 Aug; 151(3-4):220-8. PubMed ID: 21420255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of cell-mediated immune responses against recombinant HN protein of Newcastle disease virus by recombinant chicken IL-18.
    Su BS; Shen PC; Hung LH; Huang JP; Yin HS; Lee LH
    Vet Immunol Immunopathol; 2011 Jun; 141(3-4):283-92. PubMed ID: 21507491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific antibody-mediated immunity in the reproductive tract of laying chickens immunized against Newcastle disease with conventional attenuated and inactivated vaccines.
    Rauw F; Nguyen TG; Ngabirano E; Marché S; Lambrecht B
    Avian Pathol; 2017 Aug; 46(4):434-441. PubMed ID: 28290220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection of chickens against hepatitis-hydropericardium syndrome and Newcastle disease with a recombinant Newcastle disease virus vaccine expressing the fowl adenovirus serotype 4 fiber-2 protein.
    Tian KY; Guo HF; Li N; Zhang YH; Wang Z; Wang B; Yang X; Li YT; Zhao J
    Vaccine; 2020 Feb; 38(8):1989-1997. PubMed ID: 31948818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a fusion gene-based DNA prime-protein boost vaccination strategy against Newcastle disease virus.
    Khulape SA; Maity HK; Pathak DC; Ramamurthy N; Ramakrishnan S; Chellappa MM; Dey S
    Trop Anim Health Prod; 2019 Nov; 51(8):2529-2538. PubMed ID: 31209691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection and differentiation of infected from vaccinated animals by an inactivated recombinant Newcastle disease virus/avian influenza H5 vaccine.
    Lozano-Dubernard B; Soto-Priante E; Sarfati-Mizrahi D; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):242-5. PubMed ID: 20521639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
    Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK
    Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune effect of a Newcastle disease virus DNA vaccine with IL-12 as a molecular adjuvant delivered by electroporation.
    Xie P; Li Y; Li Y; Liang J; Xiang B; Lin Q; Jin J; Ding C; Xu C; Ren T
    Arch Virol; 2020 Sep; 165(9):1959-1968. PubMed ID: 32519007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.